scholarly journals The role of mTOR inhibitors in the prevention of organ rejection in adult liver transplant patients: a focus on everolimus

2014 ◽  
pp. 31
Author(s):  
Teresa Casanovas
Keyword(s):  
Liver Transplant ◽  
Mtor Inhibitors ◽  
Adult Liver ◽  
Organ Rejection ◽  
Transplant Patients

scholarly journals Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Jayapal Ramesh ◽  
Nipun Reddy ◽  
Hwasoon Kim ◽  
Klaus Mönkemüller ◽  
Shyam Varadarajulu ◽  
...  
Keyword(s):  
Liver Function ◽  
Liver Transplant ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Biliary Stones ◽  
Organ Rejection ◽  
Transplant Patients ◽  
Function Tests ◽  
Biliary Pathology

Background. Abnormal liver enzymes postorthotopic liver transplant (OLT) may indicate significant biliary pathology or organ rejection. There is very little known in the literature regarding the current role of diagnostic ERCP in this scenario. Aim. To review the utility of diagnostic ERCP in patients presenting with abnormal liver function tests in the setting of OLT. Methods. A retrospective review of diagnostic ERCPs in patients with OLT from 2002 to 2013 from a prospectively maintained, IRB approved database. Results. Of the 474 ERCPs performed in OLT patients, 210 (44.3%; 95% CI 39.8–48.8) were performed for abnormal liver function tests during the study period. Majority of patients were Caucasian (83.8%), male (62.4%) with median age of 55 years (IQR 48–62 years). Biliary cannulation was successful in 99.6% of cases and findings included stricture in 45 (21.4 %); biliary stones/sludge in 23 (11%); biliary dilation alone in 31 (14.8%); and normal in 91 (43.3%). Three (1.4%) patients developed mild, self-limiting pancreatitis; one patient (0.5%) developed cholangitis and two (1%) had postsphincterotomy bleeding. Multivariate analyses showed significant association between dilated ducts on imaging with a therapeutic outcome. Conclusion. Diagnostic ERCP in OLT patients presenting with liver function test abnormalities is safe and frequently therapeutic.

Effects ofCYP3A5genotypes,ABCB1 C3435TandG2677T/Apolymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients

Xenobiotica ◽  
2015 ◽  
Vol 45 (9) ◽  
pp. 840-846 ◽  
Author(s):  
LiQin Zhu ◽  
JianWei Yang ◽  
Yuan Zhang ◽  
YaQing Jing ◽  
YanWen Zhang ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Adult Liver ◽  
Transplant Patients ◽  
Chinese Adult

The role of immunomodulation in ABO-incompatible adult liver transplant recipients

2008 ◽  
Vol 23 (2) ◽  
pp. 55-62 ◽  
Author(s):  
Lucio Urbani ◽  
Alessandro Mazzoni ◽  
Irene Bianco ◽  
Tiziana Grazzini ◽  
Paolo De Simone ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Transplant Recipients ◽  
Adult Liver ◽  
Liver Transplant Recipients

44 AN EVALUATION OF THE IMx® II TACROLIMUS ASSAY IN ADULT LIVER TRANSPLANT PATIENTS.

1997 ◽  
Vol 19 (5) ◽  
pp. 558
Author(s):  
P J Taylor ◽  
J L Baker ◽  
S V Lynch ◽  
A G Johnson
Keyword(s):  
Liver Transplant ◽  
Adult Liver ◽  
Transplant Patients

The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma

2019 ◽  
Vol 120 (7) ◽  
pp. 1126-1136 ◽  
Author(s):  
Arno Kornberg ◽  
Ulrike Witt ◽  
Martina Schernhammer ◽  
Jennifer Kornberg ◽  
Katharina Müller ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Risk Stratification ◽  
Liver Transplant ◽  
Transplant Patients ◽  
Preoperative Albumin
Sign in / Sign up

Export Citation Format

Share Document